Drug profile · INN
sulfoxone sodium
DIASONE SODIUM
sulfoxone sodium (DIASONE SODIUM) is a dihydropteroate synthase 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — sulfoxone sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
sulfoxone sodium (DIASONE SODIUM) is a dihydropteroate synthase 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dihydropteroate synthase 1 inhibitor
Primary target: Dihydropteroate synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sulfoxone sodium?
sulfoxone sodium (DIASONE SODIUM) is a dihydropteroate synthase 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sulfoxone sodium?
DIASONE SODIUM is a marketed brand name for sulfoxone sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfoxone sodium?
sulfoxone sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.